These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 15841951)

  • 21. The WHI: the effect of hormone replacement therapy on fracture prevention.
    de Villiers TJ; Stevenson JC
    Climacteric; 2012 Jun; 15(3):263-6. PubMed ID: 22612613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Does menopause hormone therapy reduce the risk of chronic diseases?].
    Blümel JE; Arteaga E
    Rev Med Chil; 2018 Dec; 146(10):1170-1174. PubMed ID: 30724981
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Benefits of hormone replacement therapy in postmenopausal women.
    Canderelli R; Leccesse LA; Miller NL; Unruh Davidson J
    J Am Acad Nurse Pract; 2007 Dec; 19(12):635-41. PubMed ID: 18042129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Landmark hormone replacement therapy study stopped after finding more harms than benefits.
    Rollins G
    Rep Med Guidel Outcomes Res; 2002 Aug; 13(15):5-7. PubMed ID: 12553323
    [No Abstract]   [Full Text] [Related]  

  • 25. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
    Lee WL; Chao HT; Cheng MH; Wang PH
    Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Update on hormone replacement therapy.
    Gambrell RD
    Am Fam Physician; 1992 Nov; 46(5 Suppl):87S-96S. PubMed ID: 1442475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Patterns of hormone replacement therapy in a population-based cohort of postmenopausal German women. Changes after HERS II and WHI.
    Clanget C; Hinke V; Lange S; Fricke R; Botko R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2005 Oct; 113(9):529-33. PubMed ID: 16235155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beliefs about breast cancer risk and use of postmenopausal hormone replacement therapy.
    Armstrong K; Popik S; Guerra C; Ubel PA
    Med Decis Making; 2000; 20(3):308-13. PubMed ID: 10929853
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Educating patients about the benefits and drawbacks of hormone replacement therapy.
    Rozenberg S; Vasquez JB; Vandromme J; Kroll M
    Drugs Aging; 1998 Jul; 13(1):33-41. PubMed ID: 9679207
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Hormone therapy in menopause. A current update].
    Seifert-Klauss V; Schumm-Draeger PM
    Internist (Berl); 2003 Dec; 44(12):1500-7. PubMed ID: 14689192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of hormone replacement therapy on cardiovascular disease: current opinion.
    Khan NS; Malhotra S
    Expert Opin Pharmacother; 2003 May; 4(5):667-74. PubMed ID: 12739992
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postmenopausal hormone replacement therapy and major clinical outcomes: a focus on cardiovascular disease, osteoporosis, dementia, and breast and endometrial neoplasia.
    Dick SE; DeWitt DE; Anawalt BD
    Am J Manag Care; 2002 Jan; 8(1):95-104; quiz 105-6. PubMed ID: 11814176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Hormone replacement therapy and its derivatives in the prevention and treatment of osteoporosis].
    Lamy O; Krieg MA
    Rev Med Suisse Romande; 2002 Aug; 122(8):377-81. PubMed ID: 12357730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormone replacement therapy and coronary heart disease in women: a review of the evidence.
    Low AK; Russell LD; Holman HE; Shepherd JM; Hicks GS; Brown CA
    Am J Med Sci; 2002 Oct; 324(4):180-4. PubMed ID: 12385489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hormones after menopause?
    Velkeniers B
    Acta Clin Belg; 2001; 56(2):113-21. PubMed ID: 11383314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Hormone replacement therapy in peri- and postmenopause. Routine use is not indicated].
    Emons G; Westphalen S
    MMW Fortschr Med; 2002 Feb; 144(9):30-3. PubMed ID: 11921648
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recency and duration of postmenopausal hormone therapy: effects on bone mineral density and fracture risk in the National Osteoporosis Risk Assessment (NORA) study.
    Barrett-Connor E; Wehren LE; Siris ES; Miller P; Chen YT; Abbott TA; Berger ML; Santora AC; Sherwood LM
    Menopause; 2003; 10(5):412-9. PubMed ID: 14501602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Hormone replacement therapy and the risk of developing breast cancer].
    Merz WE
    MMW Fortschr Med; 2004 Feb; 146(9):26-8, 30. PubMed ID: 15352702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine in postmenopausal women and the importance of hormone replacement therapy.
    Mijatovic V; van der Mooren MJ
    Clin Chem Lab Med; 2001 Aug; 39(8):764-7. PubMed ID: 11592448
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted?
    Alexandersen P; Karsdal MA; Christiansen C
    Womens Health (Lond); 2009 Nov; 5(6):637-47. PubMed ID: 19863467
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.